ArticleBioinformatics (Oxford, England)2026
miRBind2 enables sequence-only prediction of miRNA binding and transcript repression.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
motivationMicroRNAs (miRNAs) regulate gene expression by guiding Argonaute proteins to partially complementary sites on target RNAs. While classical prediction methods rely on engineered features such as seed match categories, evolutionary conservation, and site context, recent advances in deep learning offer the potential to learn targeting rules directly from sequence. We developed a sequence-based deep learning model that improves miRNA target site prediction, and further validated the learned target site representations by extending the model to gene-level functional repression prediction.
resultsWe introduce miRBind2, a deep learning method for miRNA target site prediction that incorporates a novel pairwise nucleotide representation capturing all possible miRNA-target nucleotide interactions, with a CNN-based architecture. miRBind2 outperforms previous SotA models across four independent datasets from the debiased miRBench benchmark, while using 92% fewer parameters. We show that the convolutional features and weights learned by miRBind2 can be transferred to transcript-level prediction by extending the miRBind2 architecture and fine-tuning it on miRNA perturbation experiments. This miRBind2-3UTR model predicts gene repression from sequence alone. On a dataset of 50 549 miRNA-gene pairs, miRBind2-3UTR significantly outperforms TargetScan. These results show that deep models pretrained on target site data can capture regulatory signals and predict functional repression without requiring conventional engineered biological features. AVAILABILITY: Models and source code are freely available via GitHub (https://github.com/BioGeMT/miRBind_2.0). A publicly available web-tool for novel predictions and visualization is available at: (https://huggingface.co/spaces/dimostzim/BioGeMT-miRBind2).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.